oldid167539

Sandoz could relocate re-analysis centre to Romania

Swiss group Sandoz, the second-largest player on the global market of generic drugs, is considering relocating its drug re-analysis centre from Germany, with the possible destinations including Romania and Poland. "Our plans include investments worth one milli...